Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more
Genic Co. Ltd (123330) - Total Liabilities
Latest total liabilities as of September 2025: ₩15.28 Billion KRW
Based on the latest financial reports, Genic Co. Ltd (123330) has total liabilities worth ₩15.28 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Genic Co. Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how Genic Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Genic Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Genic Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Perfect Medical Health Management Limited
PINK:PFSMF
|
USA | $501.93 Million |
|
Lollands Bank
CO:LOLB
|
Denmark | Dkr4.87 Billion |
|
Shaver Shop Group Ltd
AU:SSG
|
Australia | AU$71.65 Million |
|
HusCompagniet AS
CO:HUSCO
|
Denmark | Dkr1.54 Billion |
|
Peninsula Energy Ltd
OTCQB:PENMF
|
USA | $38.60 Million |
|
Pro-Hawk
TWO:8083
|
Taiwan | NT$489.56 Million |
|
Westwater Resources Inc
NYSE MKT:WWR
|
USA | $19.71 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Genic Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genic Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genic Co. Ltd (2012–2024)
The table below shows the annual total liabilities of Genic Co. Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩16.00 Billion | +34.81% |
| 2023-12-31 | ₩11.87 Billion | -17.64% |
| 2022-12-31 | ₩14.41 Billion | -44.80% |
| 2021-12-31 | ₩26.11 Billion | -5.95% |
| 2020-12-31 | ₩27.77 Billion | -10.46% |
| 2019-12-31 | ₩31.01 Billion | -9.78% |
| 2018-12-31 | ₩34.37 Billion | -12.11% |
| 2017-12-31 | ₩39.11 Billion | -1.32% |
| 2016-12-31 | ₩39.63 Billion | +36.81% |
| 2015-12-31 | ₩28.97 Billion | +42.39% |
| 2014-12-31 | ₩20.34 Billion | +73.85% |
| 2013-12-31 | ₩11.70 Billion | +62.52% |
| 2012-12-31 | ₩7.20 Billion | -- |